Pande Atul bought IMVT
May 20, 2026 · Form 4 insider transaction
Pande Atul bought 6,000 shares of Immunovant, Inc. at $8.43 per share, a transaction worth $50.6K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
6,000
Price
$8.43
Total value
$50.6K
InsiderPande Atul
Role—
CompanyImmunovant, Inc. (IMVT)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMay 20, 2026
Filing dateMay 20, 2026
Shares owned after122,731
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 26, 2025.